DERMATASIA
ActiveDERMATASIA has been active since 2023 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €176k and a net result of €79k. Equity is growing by ~78.2% per year across the filed fiscal years. Its solvency ranks better than 76% of 16527 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2025
96
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency100▲+13
Growth78=
Track record94
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €16k at 30 days acceptable
Liquidity ample (current ratio 12.31 against 3.79 in 2024; short-term debt: 6.9% and cash: 52.5% of total assets), and 15.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
84.9%
Return on assets
38.3%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-02-2026, 177 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
177 d early
2024
51 d early
2023
48 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
21-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€176k▲ 82.3%
2024 · €96k
2023: €25k
2024: €96k
2023 → 2025
Total assets
€207k▲ 32.5%
2024 · €156k
2023: €121k
2024: €156k
2023 → 2025
Net result
€79k▲ 11.2%
2024 · €71k
2023: €25k
2024: €71k
2023 → 2025
Working capital
€161k▲ 89.7%
2024 · €85k
2023: €15k
2024: €85k
2023 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202320242025Trend
Equity€25k-€96k▲ 285%€176k▲ 82.3%
Operating result€36k-€93k▲ 163%€103k▲ 9.8%
Net result€25k-€71k▲ 186%€79k▲ 11.2%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen two years in a row; 2025 is 10% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €207k
Fixed assets
€32k▼ 22.5%
Current assets
€176k▲ 52.0%
Equity and liabilities €207k
Equity
€176k▲ 82.3%
Debt
€31k▼ 47.7%
The debt ratio falls from 38.3% to 15.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€112k▲
2024 · €104k
Cash flow
€89k▲
2024 · €82k
Solvency
84.9%▲
2024 · 61.7%
Current ratio
12.31▲
2024 · 3.79
Quick ratio
11.94▲
2024 · 3.62
Debt / equity
0.18▼
2024 · 0.62
ROE
45.1%▼
2024 · 74.0%
ROA
38.3%▼
2024 · 45.7%
Interest coverage
42.46▲
2024 · 35.43
Debt
€31k▼
2024 · €60k
Debt ≤ 1 year
€14k▼
2024 · €31k
Debt > 1 year
€17k▼
2024 · €29k
Income taxes
€22k▲
2024 · €19k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€156k€207k▲
Fixed assets21/28€41k€32k▼
Tangible fixed assets22/27€41k€32k▼
Plant, machinery and equipment23€27k€24k▼
Furniture and vehicles24€14k€8k▼
Current assets29/58€115k€176k▲
Stocks and contracts in progress3€5k€5k▲
Stocks30/36€5k€5k▲
Amounts receivable within one year40/41-€404
Other amounts receivable41-€404
Current investments50/53€50k€50k=
Cash at bank and in hand54/58€57k€109k▲
Deferred charges and accrued income490/1€3k€11k▲
Equity and liabilities
Total equity and liabilities10/49€156k€207k▲
Equity10/15€96k€176k▲
Contributions10/11€100€100=
Reserves13€12k€12k=
Distributable reserves133€12k€12k=
Profit (loss) carried forward14€84k€164k▲
Amounts payable17/49€60k€31k▼
Amounts payable after more than one year17€29k€17k▼
Financial debts170/4€29k€17k▼
Amounts payable within one year42/48€31k€14k▼
Current portion of amounts payable after more than one year42€12k€12k▲
Trade debts44€3k€444▼
Suppliers440/4€3k€444▼
Taxes, remuneration and social security45€2k€2k▼
Taxes450/3€2k€2k▼
Other amounts payable47/48€13k-
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€11k€9k▼
Other operating charges640/8€241-
Gross operating margin9900€104k€112k▲
Operating profit (loss)9901€93k€103k▲
Financial income75/76B-€1k
Recurring financial income75-€1k
Financial charges65/66B€3k€3k▼
Recurring financial charges65€3k€3k▼
Profit (loss) for the period before taxes9903€90k€101k▲
Income taxes67/77€19k€22k▲
Profit (loss) for the period9904€71k€79k▲
Profit (loss) for the period to be appropriated9905€71k€79k▲
Appropriation of the result
Profit (loss) to be appropriated9906€84k€164k▲
Profit (loss) brought forward from the previous period14P€13k€84k▲
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
04-02
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2023net €79k ▲11.2%
Operating result €103k, net result €79k, both a record.
31-12
Financial
Liquidity triplescurrent ratio 12.31
Current ratio from 3.79 to 12.31; short-term debt falls from €31k to €14k.
31-12
Financial
Equity above €150kEq €176k ▲82.3%
3 profitable years in a row build equity to €176k.
10-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity triplescurrent ratio 3.79
Current ratio from 1.27 to 3.79; short-term debt falls from €55k to €31k.
13-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2023
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Jaargetijdenlaan 491050 ElseneGround area
151 m²
Building footprint
76 m²
Volume, LiDAR
894 m³
Parcel 21445C0234/00H007, Brussels · tallest building 16.0 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
DERMATASIA
since 20232.340.648.602
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21445C0234/00H007 | Brussels | 151 m² | 1 · 76 m² | 16.0 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
HOLEX
BE 1015.716.989
Fléron · Eq €176k
OMED
BE 0836.482.270
Oostkamp · Eq €176k
A.W. Cardio SC SPRL
BE 0665.700.409
Sint-Lambrechts-Woluwe · Eq €176k
HVG FYSIO
BE 0650.534.458
Antwerpen · Eq €176k
DR. PH. ALBERTYN
BE 0476.629.888
Aartselaar · Eq €176k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,821 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded05-01-2023
Fiscal year end31-12
Abbreviation FR
DMT
Activities, NACEBEL
86220Specialist medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:dermatasia@gmail.com